home All News open_in_new Full Article

NHS patients battling Alzheimer's WON'T be offered 'miracle' drugs as health watchdog rules they are 'too expensive to justify'

The National Institute for Health and Care Excellence (NICE) has refused the 'miracle' drugs lecanemab and donanemab for use on the NHS as they are too expensive to justify.


today 10 h. ago attach_file Events

attach_file Events
attach_file Events
attach_file Science
attach_file Events
attach_file Science
attach_file Science
attach_file Events
attach_file Events
attach_file Events
attach_file Events
attach_file Economics
attach_file Science
attach_file Events
attach_file Events
attach_file Science
attach_file Events
attach_file Events
attach_file Events
attach_file Science
attach_file Economics


ID: 2564721356
Add Watch Country

arrow_drop_down